A Population Pharmacokinetic and Pharmacodynamic Analysis of Abemaciclib in a Phase I Clinical Trial in Cancer Patients

Yazar: Tate, Sonya C., Sykes, Amanda K., Kulanthaivel, Palaniappan, Chan, Edward M., Turner, P. Kellie, Cronier, Damien M.
Yayımlandı Clin Pharmacokinet (2017)

SUMO Pathway Dependent Recruitment of Cellular Repressors to Herpes Simplex Virus Type 1 Genomes

Yazar: Cuchet-Lourenço, Delphine, Boutell, Chris, Lukashchuk, Vera, Grant, Kyle, Sykes, Amanda, Murray, Jill, Orr, Anne, Everett, Roger D.
Baskı/Yayın Bilgisi 2011

PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication

Yazar: Cuchet, Delphine, Sykes, Amanda, Nicolas, Armel, Orr, Anne, Murray, Jill, Sirma, Hüseyin, Heeren, Joerg, Bartelt, Alexander, Everett, Roger D.
Baskı/Yayın Bilgisi 2011

Development and Application of a Mechanistic Population Modeling Approach to Describe Abemaciclib Pharmacokinetics

Yazar: Chigutsa, Emmanuel, Kambhampati, Siva Rama Prasad, Karen Sykes, Amanda, Posada, Maria M., van der Walt, Jan‐Stefan, Turner, P. Kellie
Yayımlandı CPT Pharmacometrics Syst Pharmacol (2020)

A Randomized Phase I Study of Abemaciclib in Chinese Patients with Advanced and/or Metastatic Cancers

Yazar: Zhang, Jian, Yang, Nong, Ji, Dongmei, Shen, Weina, Li, Wenhua, Han, Rubing, Wang, Ning, Tao, Haoxun, Chapman, Sonya C., Sykes, Amanda K., Zhang, Wanli, Hu, Xichun
Yayımlandı Target Oncol (2021)

A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors

Yazar: Simon, George R., Ilaria, Robert L., Sovak, Mika A., Williams, Charles C., Haura, Eric B., Cleverly, Ann L., Sykes, Amanda K., Wagner, Margaret M., de Alwis, Dinesh P., Slapak, Christopher A., Miller, Mary A., Spriggs, David R.
Baskı/Yayın Bilgisi 2011